2 years ago

AbbVie to Buy Cerevel Therapeutics for $8.7 Billion

WSJ
2 years ago

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

CNBC
Cerevel Therapeutics

←Top Latest Headlines